PodcastCancer

Science Translational Medicine Podcast: 26 August 2015

Science Translational Medicine  26 Aug 2015:
Vol. 7, Issue 302, pp. 302pc3
DOI: 10.1126/scitranslmed.aad1902

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

In this podcast, Scott Dylla discusses a new antibody-drug conjugate that may be effective in treating high-grade pulmonary neuroendocrine cancers.

Listen to Podcast

View Full Text